This is a prospective, multicenter, open-label, comparative and parallel-group study of
ovulation induction evaluating tailoring of Recombinant follicle stimulating hormone (FSH)
treatment using the Gonal-f® prefilled pen in World Health Organization (WHO) Type 2
anovulatory subjects who have previously failed to conceive with clomifene treatment.